Skip to main content
. 2022 Jun 22;22:230. doi: 10.1186/s12883-022-02729-8

Table 4.

Pairwise comparison of outcome measures between different study time-points in the intervention group

Category Time-point Reference time-point Mean Difference Standard Error P-value 95% Confidence Interval for Difference
Visual analog scale (headache severity) 1 2 1.875 0.340  < 0.001 (1.150, 2.600)
3 2.500 0.342  < 0.001 (1.772, 3.228)
2 3 0.625 0.352 0.096 (-0.125, 1.375)
Migraine disability assessment scale (MIDAS) 1 2 21.875 4.513  < 0.001 (12.256, 31.494)
3 23.813 4.841  < 0.001 (13.494, 34.131)
2 3 1.938 0.692 0.013 (0.462, 3.413)
MIDAS-A 1 2 16.938 3.269  < 0.001 (9.970, 23.905)
3 19.563 3.217  < 0.001 (12.705, 26.420)
2 3 2.625 1.197 0.044 (0.074, 5.176)
MIDAS-B 1 2 1.594 0.369 0.001 (0.808, 2.379)
3 2.063 0.413  < 0.001 (1.182, 2.943)
2 3 0.469 0.314 0.157 (-0.202, 1.139)
Headache impact test (HIT) 1 2 6.750 1.493  < 0.001 (3.568, 9.932)
3 10.313 1.128  < 0.001 (7.908, 12.717)
2 3 3.563 1.151 0.007 (1.109, 6.016)
Hospital anxiety and depression scale-Anxiety 1 2 2.625 0.774 0.004 (0.975, 4.275)
3 3.688 0.762  < 0.001 (2.063, 5.312)
2 3 1.063 0.403 0.019 (0.204, 1.921)
Hospital anxiety and depression scale-Depression 1 2 2.063 0.433  < 0.001 (1.140, 2.985)
3 2.313 0.561 0.001 (1.118, 3.507)
2 3 0.250 0.487 0.615 (-0.789, 1.289)
Days with headache within the past 30 days 1 2 5.625 1.179  < 0.001 (3.111, 8.139)
3 8.125 1.541  < 0.001 (4.841, 11.409)
2 3 2.500 1.114 0.040 (0.125, 4.875)
Number of pain-relievers taken during the past 30 days 1 2 7.188 1.085  < 0.001 (4.875, 9.500)
3 8.688 1.413  < 0.001 (5.675, 11.700)
2 3 1.500 0.764 0.068 (-0.128, 3.128)

Results based on estimated marginal means